Disease-Modifying Therapy and Breastfeeding

Abstract

Get full access to this article

View all access options for this article.

References

Mahadevan

, Seow

, Barnes

, et al. Global consensus statement on the management of pregnancy in inflammatory bowel disease. Clin Gastroenterol Hepatol , 2025; 23(11S):S1–S60; doi: 10.1016/j.cgh.2025.04.005

Rüegg

, Pluma

, Hamroun

, et al. EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update. Ann Rheum Dis , 2025; 84(6):910–926; doi: 10.1016/j.ard.2025.02.023

Shipley

, Beharry

, Yeh

, et al. Consensus recommendations on multiple sclerosis management in Australia and New Zealand: Part 2. Med J Aust , 2025; 222(7):365–371; doi: 10.5694/mja2.52577

Jacob

, Shatila

, Inshasi

, et al. Disease modifying treatment guidelines for multiple sclerosis in the United Arab Emirates. Mult Scler Relat Disord , 2024; 88:105703; doi: 10.1016/j.msard.2024.105703

Krysko

, Dobson

, Alroughani

, et al. Family planning considerations in people with multiple sclerosis. Lancet Neurol , 2023; 22(4):350–366; doi: 10.1016/s1474-4422(22)00426-4